TearLab Corporation · San Diego, CA United States (NASDAQ: TEAR)
Key TearLab Corporation Financials
| Company Type | Public -(NASDAQ: TEAR) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Sales (mil.) | $2.1 |
| 2011 Employees | 19 |
TearLab Corporation Income Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Revenue | 2.1 | 1.7 | 0.9 |
| Cost of Goods Sold | 1.6 | 0.8 | 0.6 |
| Gross Profit | 0.5 | 0.9 | 0.3 |
| Gross Profit Margin | 23.4% | 50.1% | 34.6% |
| SG&A Expense | 6.0 | 5.2 | 3.9 |
| Depreciation & Amortization | 1.2 | 1.2 | 1.2 |
| Operating Income | (8.1) | (6.9) | (5.9) |
| Operating Margin | -379.4% | -408.2% | -682.1% |
| Nonoperating Income | (0.7) | 0.5 | (0.3) |
| Nonoperating Expenses | (0.1) | (0.2) | (0.1) |
| Income Before Taxes | (8.8) | (6.7) | (6.3) |
| Income Taxes | (1.9) | ||
| Net Income After Taxes | (8.8) | (6.7) | (4.4) |
| Continuing Operations | (8.8) | (6.7) | (4.4) |
| Discontinued Operations | -- | -- | 0.0 |
| Total Operations | (8.8) | (6.7) | (4.4) |
| Total Net Income | (8.8) | (6.7) | (4.4) |
| Net Profit Margin | -414.7% | -392.9% | -504.8% |
| Diluted EPS from Total Net Income | (0.50) | (0.47) | (0.44) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
TearLab Corporation Balance Sheet
| Assets | Dec 11 | Dec 10 | Dec 09 |
| Current Assets | |||
| Cash | 2.8 | 2.7 | 0.1 |
| Net Receivables | 0.3 | 0.4 | 0.1 |
| Inventories | 0.9 | 0.6 | 0.2 |
| Other Current Assets | 0.2 | 0.4 | 0.4 |
| Total Current Assets | 4.3 | 4.1 | 0.8 |
| Net Fixed Assets | 0.2 | 0.1 | 0.1 |
| Other Noncurrent Assets | 6.1 | 7.3 | 8.7 |
| Total Assets | 10.5 | 11.5 | 9.7 |
| Liabilities | Dec 11 | Dec 10 | Dec 09 |
| Current Liabilities | |||
| Accounts Payable | 0.2 | 0.4 | 0.4 |
| Short-Term Debt | 0.0 | 1.7 | 1.2 |
| Other Current Liabilities | 4.8 | 1.6 | 1.3 |
| Total Current Liabilities | 5.0 | 3.7 | 3.0 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 0.0 | 0.0 | 0.0 |
| Total Liabilities | 5.0 | 3.7 | 3.0 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | 5.5 | 7.9 | 6.8 |
| Total Equity | 5.5 | 7.9 | 6.8 |
| Shares Outstanding (thou.) | 20,415.0 | 14,775.4 | 9,866.7 |
All amounts in millions of US Dollars except per share amounts.
TearLab Corporation Cash Flow Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Net Operating Cash Flow | (6) | (5) | (4) |
| Net Investing Cash Flow | (0.2) | (0.1) | (0.0) |
| Net Financing Cash Flow | 6.2 | 7.2 | 1.7 |
| Net Change in Cash | 0.1 | 2.6 | (2.5) |
| Depreciation & Amortization | 1.2 | 1.2 | 1.2 |
| Capital Expenditures | (0.2) | (0.1) | (0.0) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.